These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32301063)
1. Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study. Heinemann K; Imthurn B; Marions L; Gerlinger C; Becker K; Moehner S; Faustmann T Adv Ther; 2020 May; 37(5):2528-2537. PubMed ID: 32301063 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. Techatraisak K; Hestiantoro A; Ruey S; Banal-Silao MJ; Kim MR; Seong SJ; Thaufik S; Ahlers C; Shin SY; Lee BS BMC Womens Health; 2019 May; 19(1):68. PubMed ID: 31096979 [TBL] [Abstract][Full Text] [Related]
3. Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study. Moehner S; Becker K; Lange JA; von Stockum S; Heinemann K Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():212-217. PubMed ID: 32559605 [TBL] [Abstract][Full Text] [Related]
4. Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. Ebert AD; Dong L; Merz M; Kirsch B; Francuski M; Böttcher B; Roman H; Suvitie P; Hlavackova O; Gude K; Seitz C J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):560-567. PubMed ID: 28189702 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Maiorana A; Incandela D; Parazzini F; Alio W; Mercurio A; Giambanco L; Alio L Arch Gynecol Obstet; 2017 Sep; 296(3):429-433. PubMed ID: 28664483 [TBL] [Abstract][Full Text] [Related]
6. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Leonardo-Pinto JP; Benetti-Pinto CL; Cursino K; Yela DA Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():108-111. PubMed ID: 28231497 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial. El Taha L; Abu Musa A; Khalifeh D; Khalil A; Abbasi S; Nassif J Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():205-212. PubMed ID: 34826668 [TBL] [Abstract][Full Text] [Related]
8. Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis. Becker K; Heinemann K; Imthurn B; Marions L; Moehner S; Gerlinger C; Serrani M; Faustmann T Sci Rep; 2021 Oct; 11(1):20404. PubMed ID: 34650132 [TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. Kitawaki J; Kusuki I; Yamanaka K; Suganuma I Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232 [TBL] [Abstract][Full Text] [Related]
11. Dienogest in the treatment of endometriosis: systematic review. Andres Mde P; Lopes LA; Baracat EC; Podgaec S Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Römer T Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of dienogest treatment of clinical symptoms of rectovaginal endometriosis. Papíková Z; Hudeček R; Ventruba P; Szypulová M Ceska Gynekol; 2019; 84(5):331-336. PubMed ID: 31826628 [TBL] [Abstract][Full Text] [Related]
14. A systematic review and Bayesian analysis of the adverse effects of dienogest. Li RR; Xi Q; Tao L; Sheng W; Zhao CC; Wu YJ BMC Pharmacol Toxicol; 2024 Aug; 25(1):43. PubMed ID: 39090694 [TBL] [Abstract][Full Text] [Related]
15. Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN. Techatraisak K; Hestiantoro A; Soon R; Banal-Silao MJ; Kim MR; Seong SJ; Hidayat ST; Cai L; Shin S; Lee BS Reprod Sci; 2022 Apr; 29(4):1157-1169. PubMed ID: 35112299 [TBL] [Abstract][Full Text] [Related]
16. Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study. Yu Q; Zhang S; Li H; Wang P; Zvolanek M; Ren X; Dong L; Lang J J Womens Health (Larchmt); 2019 Feb; 28(2):170-177. PubMed ID: 30461337 [TBL] [Abstract][Full Text] [Related]
17. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study. Cho B; Roh JW; Park J; Jeong K; Kim TH; Kim YS; Kwon YS; Cho CH; Park SH; Kim SH Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358 [TBL] [Abstract][Full Text] [Related]
18. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Petraglia F; Hornung D; Seitz C; Faustmann T; Gerlinger C; Luisi S; Lazzeri L; Strowitzki T Arch Gynecol Obstet; 2012 Jan; 285(1):167-73. PubMed ID: 21681516 [TBL] [Abstract][Full Text] [Related]
19. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study. Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646 [TBL] [Abstract][Full Text] [Related]
20. Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study. Becker CM; Johnson NP; As-Sanie S; Arjona Ferreira JC; Abrao MS; Wilk K; Imm SJ; Mathur V; Perry JS; Wagman RB; Giudice LC Hum Reprod; 2024 Mar; 39(3):526-537. PubMed ID: 38243752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]